UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

(Check one): ¨  Form 10-K     ¨  Form 20-F     ¨  Form 11-K     þ  Form 10-Q     ¨  Form 10-D     ¨  Form N-SAR

                       ¨  Form N-CSR

                      For Period Ended: January 31, 2009

 

¨ Transition Report on Form 10-K
¨ Transition Report on Form 20-F
¨ Transition Report on Form 11-K
¨ Transition Report on Form 10-Q
¨ Transition Report on Form N-SAR

For the Transition Period Ended: ___________________________

 

 

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

 

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I — REGISTRANT INFORMATION

Biopure Corporation

Full Name of Registrant

Not applicable.

Former Name if Applicable

11 Hurley Street

Address of Principal Executive Office (Street and Number)

Cambridge, Massachusetts 02141

City, State and Zip Code

PART II — RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

     (a)   The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
 
     (b)   The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
 
þ       (c)   The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III — NARRATIVE

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

The registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2009 could not be filed by the prescribed due date of March 17, 2009 due to staffing limitations and staff illness. Accordingly, the registrant is unable to file such report within the prescribed time period without unreasonable effort or expense.

PART IV — OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

 

Zafiris G. Zafirelis

 

(617)

 

234-6500

(Name)   (Area Code)   (Telephone Number)

 

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).

Yes  ¨     No  þ

The form 10KA for the fiscal year ended October 31, 2008: due March 2, 2009, filed March 3, 2009.

 

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

Yes  ¨     No  þ

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

Biopure Corporation

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

   
Date   March 17, 2009     By   /s/ Zafiris G. Zafirelis
       

Zafiris G. Zafirelis

President and Chief Executive Officer

Biopure (MM) (NASDAQ:BPUR)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Biopure (MM) Charts.
Biopure (MM) (NASDAQ:BPUR)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Biopure (MM) Charts.